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Effects of Aβ exposure on long-
term associative memory and its 
neuronal mechanisms in a defined 
neuronal network
Lenzie Ford, Michael Crossley, Thomas Williams†, Julian R. Thorpe, Louise C. Serpell & 
György Kemenes
Amyloid beta (Aβ ) induced neuronal death has been linked to memory loss, perhaps the 
most devastating symptom of Alzheimer’s disease (AD). Although Aβ -induced impairment of 
synaptic or intrinsic plasticity is known to occur before any cell death, the links between these 
neurophysiological changes and the loss of specific types of behavioral memory are not fully 
understood. Here we used a behaviorally and physiologically tractable animal model to investigate 
Aβ -induced memory loss and electrophysiological changes in the absence of neuronal death in 
a defined network underlying associative memory. We found similar behavioral but different 
neurophysiological effects for Aβ 25-35 and Aβ 1-42 in the feeding circuitry of the snail Lymnaea 
stagnalis. Importantly, we also established that both the behavioral and neuronal effects were 
dependent upon the animals having been classically conditioned prior to treatment, since Aβ 
application before training caused neither memory impairment nor underlying neuronal changes over 
a comparable period of time following treatment.
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder in the Western world, affect-
ing an estimated 24.3 million individuals globally. AD is characterized by progressive memory loss and 
the prominent markers are extracellular amyloid plaques, made of amyloid β (Aβ ), and intracellular 
neurofibrillary tangles, composed of hyperphosphorylated tau1. Aβ are secreted peptides that have been 
cleaved from the amyloid precursor protein (APP)2, with the oligomeric form of the peptide being widely 
regarded as the toxic structure3. The role of Aβ as a toxic element in the disease has been widely explored 
through multiple techniques, including in vivo and in vitro application of synthetic peptides as well 
as in novel transgenic mouse models created to overexpress Aβ . Transgenic models, such as Tg2576, 
have shown a correlation between increased Aβ production in the brain and decreased performance in 
numerous memory tasks4. Many laboratories have studied the effect of Aβ using varying fragments of 
the Aβ peptide, model system, and concentration applied, collectively agreeing that Aβ interferes with 
long term potentiation (LTP) and early memory5–7. However, contrasting results exist between different 
transgenic mouse lines, types of memory being tested, and areas of the brain being observed (for review, 
see8). These contradictions are widespread in the Aβ field. A common problem is that experiments are 
often performed on animals, cells, or tissues that are already exhibiting neurodegenerative properties, 
potentially masking any early-stage symptoms of Aβ treatment. Death of the neurons that encode a 
memory trace will inevitably be manifested as a behavioral deficit. However, synaptic dysfunction and 
impairment of intrinsic plasticity have been found to occur before neuronal cell death in Aβ models, 
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causing sufficient disturbance to result in learning and memory dysfunction3,9–12. We believe that these 
early-stage disruptions are excellent targets for drug and clinical interference with AD and that more 
emphasis needs to be placed on pre-cell death studies.
For this reason, we have examined the effects of Aβ treatment on the maintenance of established 
long-term memory (LTM) and underlying neuronal properties in the pond snail, Lymnaea stagnalis, 
with no signs of cell death in the neuronal circuitry for feeding that both acquires and stores the implicit 
memory trace after food-reward classical conditioning13. Invertebrates are used for their simplicity and 
ability to allow techniques to be used that would be extremely difficult, if not impossible, to accomplish 
in a mammalian model. Lymnaea provides a highly tractable model system that is well established in the 
learning and memory field for its uses in behavioral, electrophysiological, molecular, and cellular net-
work experimentation, allowing for both in vivo and in vitro approaches14. The use of Lymnaea allows a 
top-down approach to be taken, with multiple techniques being used on the same individual animals and 
same specific neurons. This allows for a direct link to be established between peptide administration and 
behavioral and neuronal changes, a crucial component to Aβ research that is currently lacking in other 
models. Previous work in a similar snail model has found that Helix lucorum were unable to learn a con-
ditioned food aversion reflex when repeatedly injected with high concentrations of Aβ 25-35, 24 hours 
before and 72 hours after training, in conjunction with a 5-day multi-trial training protocol. Moreover, 
facilitation of synaptic responses was significantly reduced when the central nervous system was exposed 
to Aβ 25-3515. However, the effect of Aβ treatment on consolidated memory was not investigated in Helix 
and has been a relatively unexplored form of memory throughout the literature. Consolidated memory 
was successfully investigated by Lesne et al. 200616, where they administered Aβ dodecamers into rat 
brains two weeks post-training, allowing the group to conclude that Aβ disrupted consolidated memory 
but not memory acquisition.
Here, we used a pre-cell death Aβ incubation time point combined with a single-trial food-reward 
classical conditioning paradigm to investigate the effects of Aβ on associative LTM in Lymnaea. We 
found that snails treated with either a short amyloidogenic fragment (Aβ 25-35) or full-length Aβ 1-42 
had significantly impaired memory 24 hours after treatment. We also found that memory loss associated 
with administration of Aβ 25-35 was correlated with impaired non-synaptic plasticity in key neurons 
within the memory and feeding network, whilst Aβ 1-42 affected memory through impairing a different, 
possibly synaptic, mechanism. Importantly, Aβ induced changes in behavior and neuronal properties 
only occurred when training preceded injection, suggesting a detrimental effect on memory maintenance 
or late/lingering consolidation rather than acquisition.
Results
Systemically applied Aβ 1-42 enters the snail brain. One benefit of using Lymnaea stagnalis in 
behavioral pharmacological studies is that the animal has no blood-brain barrier17; therefore, it is not 
necessary to directly apply Aβ to the brain tissue and the Aβ concentration can be kept low and well con-
trolled for each individual animal. We used this to our advantage and monitored the entry of systemically 
injected Aβ into the buccal and cerebral ganglia, which contain all the circuitry involved in memory after 
food-reward conditioning13. An Alexa Fluor 488 Protein Labeling Kit was used to tag freshly prepared Aβ 
1-42 (see Methods). The peptide was measured with respect to fluorescence and degree of labeling. The 
freshly prepared Alexa Fluor 488- tagged Aβ was immediately injected into the animals at the working 
concentration of 1 μ M and allowed to incubate in vivo for 24 hours. Whole brains were dissected and 
desheathed of the perineurium, the protective connective tissue, and viewed using a fluorescence micro-
scope. While non-specific tissue autofluorescence does exist in snail neurons, possibly masking some of 
the fluorescence of the 1 μ M Aβ 1-42, samples from animals treated with the tagged peptide exhibited 
distinct fluorescent punctae indicating the presence of Aβ 1-42 (Fig. 1a–d).
The areas with the highest degree of labeling appeared to be where perineurium remained around the 
ganglia, with some possible labeling inside the ganglionic tissue. Although these results indicated that Aβ 
1-42 reaches the snail brain within 24 hours after systemic injection, we were unable to establish if Aβ 
1-42 actually penetrated the ganglia and neurons using light microscopy alone. Therefore, we used the 
same Alexa Fluor 488-tagged Aβ 1-42 treated ganglia and viewed immunogold labeled sections under 
the transmission electron microscope (TEM). Using a primary antibody specific for the Alexa Fluor 488 
tag and a 10 nm gold-tagged secondary antibody, we were able to visualize the location of Aβ 1-42 at 
the ultrastructural level. Figure  1e–g reveals Alexa Fluor 488-tagged Aβ within the ganglia and these 
peptides can be tracked throughout the brain tissue and inside cells. Upon determining that Aβ 1-42 
does enter ganglia and cells, we focused on organelles with a high degree of labeling. Aβ 1-42 labeling 
was found within the nucleus, mitochondria, and dense-core granules/vesicles (Supplementary Fig. 1). 
There were also areas of highly labeled perineurium (Supplementary Fig. 1), suggesting that much of 
the systemically applied Aβ 1-42 gets caught in the connective tissue surrounding the brain.
Oligomeric Aβ is present in the hemolymph 24 hours after injection. As the oligomeric forms 
of Aβ peptides are widely regarded as the toxic structure3, we conducted an experiment in which we 
administered either 1 μ M Aβ 1-42, 0.1 mM Aβ 25-35 (based on the use of this concentration in Helix15, 
also see below), or vehicle, and incubated the animals for 24 hours before their hemolymph (body 
fluid), was extracted and subjected to formic acid extraction to select for soluble Aβ (see Methods). The 
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hemolymph extracts were added to TEM grids, negative stained, and labeled with the oligomer-specific 
Nu1 primary antibody18 and a 10 nm gold-conjugated secondary antibody. Immunogold particles were 
observed in large numbers in both peptide-treated hemolymph samples (Fig. 2a,b), but were negligibly 
detected in vehicle-treated controls (Fig. 2c). Notably, Aβ 1-42 has significantly more Nu1- labeling than 
Aβ 25-35 regardless of the 100-fold higher injected concentration of Aβ 25-35 (Fig. 2d). The presence 
of these immunogold particles in the hemolymph extracts indicates that even at 24 hours after systemic 
administration, soluble and oligomeric Aβ 1-42 and Aβ 25-35 are still available for uptake by the nerv-
ous system and that Aβ 1-42 remains in a more oligomeric form than Aβ 25-35 after 24 hours in vivo.
Both Aβ 25-35 and Aβ 1-42 disrupt consolidated long-term memory. The short fragment pep-
tide Aβ 25-35 has been shown to have neurotoxic properties and to affect cognitive processes19, and 
has been used successfully in another molluscan model15. The fragment represents the core functional 
domain of the full length Aβ peptide and is able to self-assemble to form a predominantly β -sheet 
structure. For this reason, it has been used to test the effects of Aβ exposure19. Therefore, our initial 
experiments to test the effect of Aβ on behavior were conducted with Aβ 25-35. Animals were classi-
cally conditioned using a food-reward training paradigm (Fig. 3a). Treatment with 0.1 mM Aβ 25-35 at 
24 hours after training significantly reduced the animals’ feeding response to the conditioned stimulus 
(CS) tested 24 hours after injection and 48 hours after training (Fig. 3b). This concentration was inves-
tigated due to its demonstrated effect on memory in Helix15. However, 0.1 mM Aβ 25-35 is considered 
to be a rather high concentration, so we administered a more commonly used concentration of 1 μ M 
Aβ 25-35 for comparison. The data showed a trend for decreased memory but no significant memory 
impairment (Fig. 3b), therefore all subsequent experiments were conducted using 0.1 mM Aβ 25-35.
While Aβ 25-35 (racemized at D-Ser26) has been immunohistochemically detected in plaques of AD 
brains20, the peptide is not actively cleaved from the APP protein. Therefore, the effect of Aβ 1-42, the 
most toxic of the Aβ peptides with a widely accepted physiological relevance, was also examined. At 
1 μ M, Aβ 1-42 significantly reduced the animals’ feeding response to the CS (Fig.  3b). As a control, 
trained animals were injected with vehicle and no memory impairment was observed. Therefore, the 
behavioral effect observed is not a result of either the buffer the Aβ is solubilized in or the injection itself. 
Both 1 μ M Aβ 1-42 and 0.1 mM Aβ 25-35 decreased the animals’ response rates to baseline, naïve levels. 
Figure 1. AlexaFluor 488-tagged Aβ 1-42 (1 μM) reaches and penetrates the snail brain within 24 hours 
of in vivo incubation. (a–d) Wholemount fluorescent images of 1 μ M AlexaFluor-Aβ , or vehicle treated 
brains after 24 hour in vivo incubation. Representative fluorescent images of untreated (a and c) and Aβ 
treated (b and d) desheathed buccal and cerebral ganglia. Yellow asterisks indicate the likely presence of 
AlexaFluor-Aβ . Scale bars represent 100 μ m. (e–g) Immunogold labeled transmission electron micrographs 
of 1 μ M AlexaFluor-Aβ , 24 hour in vivo incubation cerebral ganglia sections. 10 nm gold labels indicate 
the presence of Alexafluor-Aβ outside of the ganglia (e) as well as inside the cellular projections near the 
ganglion edge (f) There is also an accumulation of gold labeled Aβ within cellular projections, well within 
the ganglia (g) Gold labels within cells indicate that Aβ enters cells (top insert in g) but Aβ also localizes 
outside of the cell membrane (bottom insert in g). Scale bars represent 0.5 μ m.
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Importantly, neither peptide affected the unconditioned feeding response to sucrose when tested 24 hours 
after systemic injection (Supplementary Fig. 2a). The lack of feeding response to the CS therefore was 
not due to an impairment of the animals’ ability to generate the feeding motor pattern, which also indi-
cates that the circuitry, within which the memory is encoded, is functioning healthily.
Figure 2. Oligomeric Aβ is found in the hemolymph after 24 hour in vivo incubation. (a–c) Micrographs 
of negative stained and Nu1 immunogold labeled, formic acid extracted hemolymph from animals treated 
with either 1 μ M Aβ 1-42 (a) 0.1 mM Aβ 25-35 (b) or vehicle (c) after 24 hour in vivo incubation. Circles 
represent immunogold labels counted. Scale bars represent 100 nm. (d) Quantitative comparison of 
immunogold labels present in x20k magnification micrographs. Aβ 1-42 n = 4, Aβ 25-35 n = 24, Vehicle 
n = 13. Means ± SEM values are shown. Asterisks indicate significant differences in the number of gold 
particles per image between groups. One-way ANOVA, p < 0.0001. Tukey’s tests with p < 0.001: Aβ 1-42 vs 
Aβ 25-35 and Aβ 1-42 vs Vehicle. Tukey’s tests with p < 0.05: Aβ 25-35 vs Vehicle.
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Aβ 1-42 and Aβ 25-35 do not cause neuronal death or network dysfunction after 24 hours 
in vivo incubation. The most obvious cause of Aβ ’s detrimental effect on memory would be the 
induction of cell death in the memory-encoding circuitry. We intended to observe pre-neuronal death 
time points in these experiments and so used four different indicators to monitor possible apoptosis or 
necrosis.
First, we tested the unconditioned feeding response to sucrose to monitor circuitry function through 
behavioral methodology. If Aβ -induced neuronal death was occurring within the memory and feeding 
network, the animals would not have a response rate to the unconditioned stimulus (US) as high as 
the uninjected, naive group since both the conditioned and unconditioned feeding motor program are 
controlled by the same neuronal circuit13. However, there was no statistical difference among the uncon-
ditioned feeding response rates of the 0.1 mM Aβ 25-35, 1 μ M Aβ 25-35, 1 μ M Aβ 1-42 injected and 
untreated animals (Supplementary Fig. 2a) already indicating that the feeding network was functioning 
properly.
Second, we used TEM to examine ganglionic sections from treated animals for evidence of apoptotic 
morphology within neurons. No evidence of apoptosis was observed in 1 μ M Aβ 1-42 or 0.1mM Aβ 
25-35 treated animals when compared to vehicle-injected animals and scored for health of the nucleolus, 
nuclear envelope, chromatin, and cell membrane (Supplementary Fig. 2b–h).
Third, we used an Annexin V-Alexa Fluor 488 label on ganglionic sections from either 0.1 mM Aβ 
25-35, 1 μ M Aβ 1-42 injected, or vehicle injected animals and imaged them using fluorescence micros-
copy. These images were compared to sections with no Annexin V-Alexa Fluor 488 label as a method 
control. Annexin V will bind to phosphatidylserine (PS) on the cellular membrane when cells undergo 
apoptosis, so higher signal intensity in sections from the Aβ treated animals compared to vehicle controls 
would indicate Aβ-induced apoptosis in the snail brain. However, fluorescence signal intensity did not 
differ statistically among 0.1 mM Aβ 25-35, 1 μ M Aβ 1-42 and vehicle injected animals (Fig. 4a, exam-
ples in Fig.  4b–d), indicating that there is no increased apoptosis in Aβ treated animals compared to 
the vehicle control. The significantly lower level of fluorescence in the method control (Fig. 4a, example 
in Fig.  4e) suggests that only about 30 to 40% of the fluorescence seen in the experimental groups is 
Figure 3. Aβ treatment leads to memory loss. (a) Time line of the experiment. (b) Five starved animal 
groups (0.1 mM Aβ 25-35, n = 18; 1 μ M Aβ 25-35, n = 24; 1 μ M Aβ 1-42, n = 55; vehicle, n = 96; naïve, 
n = 55) were tested for rasp rate to amyl acetate, a measure of the feeding response to the CS. Means ± SEM 
values are shown. Asterisks indicate behavioral responses that are significantly lower than those in the 
vehicle treated group. One-way ANOVA, p = 0.0001. Tukey’s tests with p < 0.05: Vehicle vs. Naïve, Aβ 1-42 
vs. Vehicle, 0.1 mM Aβ 25-35 vs. Vehicle.
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non-specific background fluorescence, likely due to the well-known autofluorescence of the snail gan-
glionic tissue. The rest of the fluorescent signal seen in the Aβ and vehicle treated groups is most likely 
due to the baseline Annexin V level found naturally in cells.
Finally, we used a TUNEL assay on ganglionic sections from either 0.1 mM Aβ 25-35, 1 μ M Aβ 1-42 
injected, or vehicle injected animals and again imaged them using fluorescence microscopy. These images 
were compared to sections with no TUNEL reagent applied as a negative control and to ganglionic sec-
tions treated with DNase I as a positive control. TUNEL will bind the terminal end of nucleic acids after 
DNA fragmentation, an indicator of cell death, so a high signal would indicate a high level of apoptosis. 
However, TUNEL signal intensity did not differ significantly among the 0.1 mM Aβ 25-35, 1 μ M Aβ 1-42 
and vehicle injected experimental groups (Fig.  5a, examples in Fig.  5b–d) or among the experimental 
groups and the negative control group (Fig. 5a, examples in Fig. 5b–e). All three experimental groups, as 
well as the negative control, showed significantly less signal than the positive control (Fig. 5a, examples 
in Fig. 5b–f).
The lack of behavioral, morphological, protein and DNA indicators of cell death, for both the 1 μ M 
Aβ 1-42 and the 0.1 mM Aβ 25-35, along with the memory impairment observed with both peptides in 
the previous experiment (Fig. 3b), justified the use of these concentrations to investigate pre-cell death 
effects of Aβ 1-42 and Aβ 25-35 on identified neurons of the learning and memory circuit.
24 hours in vivo incubation with Aβ alters neuronal properties. The finding that both Aβ 25-35 
and Aβ 1-42 impair established LTM without causing cell death led us to hypothesize that one or both 
of these peptides alters the electrical properties of key neurons known to be involved in the maintenance 
Figure 4. Aβ 25-35 and Aβ 1-42 do not cause apoptosis after 24 hour incubation. I. Annexin V assay. (a) 
Graphical representation of the amount of Annexin V, measured using an Alexa Fluor 488 signal. Ganglionic 
sections from four animal groups were imaged (Aβ 1-42, n = 28; Aβ 25-35, n = 18; Vehicle, n = 22; 
unlabeled naïve (method control), n = 10). Means ± SEM values are shown. Although signal intensity in each 
of the three experimental groups is significantly higher (asterisks) than that in the method control group, 
which only shows background autofluorescence (One-way ANOVA, p = 0.0003. Tukey’s tests, p < 0.05), the 
signal intensity is not significantly different (n.s.) among the experimental groups (Tukey’s tests, p > 0.05). 
(b) Representative fluorescence image of an Aβ 1-42 treated ganglionic tissue, labeled with Annexin V- 
Alexa Fluor 488. (c) Representative fluorescence image of an Aβ 25-35 treated ganglionic tissue, labeled with 
Annexin V- Alexa Fluor 488. (d) Representative fluorescence image of a vehicle treated ganglionic tissue, 
labeled with Annexin V- Alexa Fluor 488. (e) Representative fluorescence image of ganglionic tissue from 
naive animals, with no Annexin V- Alexa Fluor 488 added. Scale bars represent 100 μ m.
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of LTM in Lymnaea. One such identified neuron type is the paired Cerebral Giant Cells (CGCs) that 
show a long lasting membrane potential depolarization after single-trial food-reward classical condi-
tioning21 (Supplementary Fig. 3a,b). This depolarization emerges over a period of between 18 and 
24 hours post-training, so it is involved in memory maintenance or late/lingering consolidation rather 
than acquisition or early consolidation21. Depolarization of the CGCs was found to be sufficient for the 
feeding response to be evoked by the CS after 24 hours post-training21,22. In a set of electrophysiolog-
ical experiments, we therefore investigated if Aβ treatment of intact animals at 24 hours post-training 
affects a number of key electrical properties of the CGCs, including membrane potential, spike shape, 
and membrane resistance. Comparisons were also made with CGCs in preparations from control ani-
mals that were either naïve, or trained and injected with vehicle at the same time when the other three 
groups were treated with 0.1 mM Aβ 25-35, 1 μ M Aβ 25-35, or 1 μ M Aβ 1-42. Explicitly unpaired train-
ing does not cause electrical changes in the CGCs21 and so the use of this type of control in the pres-
ent experiments was not necessary. Previous work has established that single-trial classical food-reward 
conditioning results in the delayed persistent depolarization of the CGCs by between 3 and 10 mV21,22. 
This result was replicated in our experiments (Fig.  6a,b), where the CGC membrane potential in the 
conditioned, vehicle-injected group of animals was more depolarized (by 5 mV on average) compared 
with preparations from naive animals. In accordance with previous findings21, classical conditioning did 
not result in significant changes in somal spike frequency, amplitude, peak, after-hyperpolarization, and 
half-width. These key parameters of the CGC action potentials were also not affected by treatment with 
the Aβ peptides (Supplementary Fig. 4), providing further confirmation of the health of the soma and 
the spike generating zones of the axon of these important neurons of the learning and memory circuitry.
Importantly, we found that Aβ 25-35 and Aβ 1-42 differed in their effects on the CGC membrane 
potential after classical conditioning. 0.1 mM Aβ 25-35 repolarized the membrane potential from a 
trained level to the level measured in naïve animals (by about 5 mV on average) while Aβ 1-42 had no 
effect (Fig. 6a,b). Similar to the behavioral results, the CGC membrane potential of the 1 μ M Aβ 25-35 
Figure 5. Aβ 25-35 and Aβ 1-42 do not cause apoptosis after 24 hour incubation. II. TUNEL assay. (a) 
Graphical representation of the amount of TUNEL signal in ganglionic sections from five animal groups (Aβ 
1-42, n = 12; Aβ 25-35, n = 7; Vehicle, n = 7; negative control, n = 6; positive control, n = 3). Means ± SEM 
values are shown. The asterisk indicates significantly higher signal intensity in the positive control group 
compared against each of the other groups (One-way ANOVA, p < 0.0001. Tukey’s tests, p < 0.05). The 
signal intensity is not significantly different (n.s.) among the three experimental and the negative control 
group (Tukey’s tests, p > 0.05). (b–f) Representative fluorescence images of ganglionic sections in the three 
experimental and two control groups. (b) Aβ 1-42 treated, labeled with TUNEL, (c) Aβ 25-35 treated, 
labeled with TUNEL, (d) Vehicle treated, labeled with TUNEL, (e) Negative control, labeled with Labeling 
Solution only, (f) Positive control, labeled with TUNEL. Scale bars represent 50 μ m.
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treated group was somewhere in between those of the 0.1 mM Aβ 25-35 and 1 μ M Aβ 1-42 groups 
(Fig. 6a,b). However, both concentrations of Aβ 25-35 caused a significant reduction of the CGC’s mem-
brane resistance compared to naïve animals whereas there was no significant difference among the other 
groups (Fig.  6c,d). These findings suggest that 0.1 mM Aβ 25-35 at least partially causes the observed 
memory loss through altering membrane properties of key neurons in the network, while Aβ 1-42 is 
altering memory through different, possibly synaptic, mechanisms.
Figure 6. Electrophysiological effects of Aβ treatment. (a) Examples of electrophysiological recordings 
of CGC membrane potential and tonic firing activity under different treatment conditions. (b) Membrane 
potential data, represented graphically (1 μ M Aβ 1-42, n = 12; 1 μ M Aβ 25-35, n = 12; 0.1 mM Aβ 25-35, 
n = 15; vehicle, n = 26; naïve, n = 26). Means ± SEM values are shown. Asterisks indicate significantly weaker 
membrane depolarization in comparison to the vehicle-treated group. One-way ANOVA, p < 0.0001. Tukey’s 
tests with p < 0.05: 1 μ M Aβ 1-42 vs. 0.1 mM Aβ 25-35, Vehicle vs. Naïve, Vehicle vs 0.1 mM Aβ 25-35. 
(c) Examples of electrophysiological recordings of CGC membrane resistance under different treatment 
conditions. (d) Membrane resistance data, represented graphically (1 μ M Aβ 1-42, n = 12; 1 μ M Aβ 25-35, 
n = 11; 0.1 mM Aβ 25-35, n = 15); vehicle, n = 24; naïve, n = 25). Means ± SEM values are shown. Asterisks 
indicate data that are significantly different than the vehicle-treated group. One-way ANOVA, p < 0.01. 
Tukey’s tests with p < 0.05: 1 μ M Aβ 25-35 vs Naïve and 0.1 mM Aβ 25-35 vs Naïve.
www.nature.com/scientificreports/
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The differences between the effects of the two peptides is possibly due to structural differences; there-
fore the morphology of Aβ 1-42 and Aβ 25-35 were examined over an assembly time of 24 hours in vitro. 
Electron micrographs showed that Aβ 25-35 forms small crystalline structures that develop into larger 
elongated crystalline structures after 24 hours. In contrast, Aβ 1-42 formed small, spherical oligomeric 
species that developed into protofibrils and then mature fibrils after 24 hours (Supplementary Fig. 5). 
The difference in morphology may account for the observed differences in cellular interactions.
Training is required to induce behavioral and neuronal vulnerability to Aβ.  Previous studies 
have found that memory is impaired following multiple applications of Aβ 22,23 or in a transgenic animal 
that over-produces Aβ 6,24. However, these impairments arise from prolonged exposure to significant 
amounts of Aβ . Other studies have also looked at single injections of Aβ , but paired with multiple train-
ing trials25–27. This alters the time point being viewed and thus makes the ability to distinguish between 
memory acquisition and other stages, such as late stage consolidation, very difficult if not impossible. 
Our single-trial conditioning and pre-training single Aβ injection paradigm showed that treatment does 
not hinder memory acquisition at 1 μ M Aβ 1-42 or 0.1 mM Aβ 25-35 concentrations when these pep-
tides were applied immediately before training and allowed to incubate 24 hours in vivo (Fig. 7a,b). The 
effect of Aβ 25-35 applied at 1 μ M concentration was not investigated due to the lack of behavioral 
response and lack of CGC membrane potential repolarization we found in the 24 hour post-injection 
tests, 48 hours after classical conditioning. Similar to the vehicle group, both Aβ 1-42 and Aβ 25-35 
treated animals produced a significantly increased feeding response to the CS in comparison to naive 
animals.
We extended this study to analyze the effect of 1 μ M Aβ 1-42 or 0.1 mM Aβ 25-35 injections applied 
immediately before training and allowed to incubate 48 hours in vivo (Supplementary Fig. 6a). By 
48 hours post-training and post-injection, conditioned feeding response levels after both Aβ 1-42 and 
Aβ 25-35 treatment are significantly decreased, back to naïve levels, when compared to vehicle-injected 
animals (Supplementary Fig. 6b). These two experiments together brought to light the importance of the 
duration of the incubation with Aβ relative to memory phases. In Lymnaea, LTM is fully consolidated at 
24 hours post-training and conditioned responses can be maintained for up to 14 days post-training14, so 
Figure 7. Aβ 1-42 and Aβ 25-35 exert their effects only after classical conditioning. (a) Time line of 
the experiment. (b) Four starved animal groups (Aβ 1-42, n = 27; Aβ 25-35, n = 30; vehicle, n = 16; naïve, 
n = 16) were tested for the feeding response to the CS 24 hours after injection and training. Means ± SEM 
values are shown. Asterisks indicate responses that are significantly higher than those in the naive group. 
One-way ANOVA, p = 0.0039. Tukey’s tests with p < 0.05: Vehicle vs. Naïve, Aβ 1-42 vs. Naïve, Aβ 25-35 vs. 
Naïve. (c) Examples of electrophysiological recordings of CGC membrane potential and tonic firing activity 
under different treatment conditions. (d) Examples of electrophysiological recordings of CGC membrane 
resistance under different treatment conditions. (e) The membrane potential data, represented graphically 
(Aβ 25-35, n = 9; vehicle, n = 5). Means ± SEM values are shown. t-test, p = 0.11. (f) The membrane 
resistance data, represented graphically (Aβ 25-35, n = 9; vehicle, n = 5). Means ± SEM values are shown. 
t-test, p = 0.26.
www.nature.com/scientificreports/
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the difference in the effects of Aβ injection before training on 24 hour versus 48 hour memory is not due 
to testing different forms of memory at these two different time points. Instead, the difference observed 
here is likely due to the amount of time that Aβ is allowed to incubate in vivo. As we did not test for 
neuronal death after 48 hours of incubation, we cannot rule out that this had occurred by this later 
post-injection time point in the feeding and memory network. Although we show that Aβ does not affect 
the acquisition of 24-hour memory, it is possible that if the peptide is allowed to incubate long enough 
to disrupt the network, appropriate memory retrieval is not possible. However, the most parsimonious 
explanation for the deleterious effects of both Aβ peptides on memory at 48 hours is that at 24 hours 
post-training and post-injection there are still sufficient amounts of oligomeric peptides available to 
interfere with the consolidated memory trace, as was also indicated by our measurements of oligomeric 
peptide levels in the hemolymph (see Fig. 2).
We further tested the idea of training-induced susceptibility of neurons to Aβ-induced electrophysi-
ological changes by testing CGCs in preparations made from naive, vehicle-injected animals and naive, 
Aβ 25-35-injected animals 24 hours after injection. This experiment established that in the absence of 
training, Aβ 25-35 did not cause membrane repolarization or decrease membrane resistance (Fig. 7c–f). 
These electrophysiological results, along with the behavioral data, suggest that training must precede Aβ 
25-35 injection in order to observe any change in membrane properties and that training must precede 
injection in order to observe a behavioral change after 24 hours of incubation with either peptide. This 
suggests that either Aβ has no effect on memory acquisition or needs training to precede peptide expo-
sure to disrupt the system.
Discussion
We have identified a direct link between administration of Aβ and loss of consolidated LTM in Lymnaea, 
a well-established and highly tractable model system for studying evolutionarily conserved cellular and 
molecular mechanisms of memory function and dysfunction14. Importantly, our study revealed that sys-
temically applied Aβ is able to enter the neurons of the ‘learning ganglia’ and leads to memory impair-
ment at the behavioral level without any evidence for neuronal death. Both 1 μ M Aβ 1-42 and 0.1 mM 
Aβ 25-35 caused significant memory impairment when injected 24 hours after training; however, only 
0.1 mM Aβ 25-35 removed the training-induced membrane potential depolarization and lowered mem-
brane resistance of a key neuron of the learning and memory circuitry. This is an important finding, as 
currently the two peptides are often used interchangeably throughout the literature. Although the pep-
tides both caused similar behavioral dysfunction in Lymnaea, they affected the same identified neuron 
type in drastically different manners. Notably, we have demonstrated that 24 hours after injection, oli-
gomeric forms of both Aβ 1-42 and Aβ 25-35 are present in the hemolymph. These toxic structures3,5,28 
may be responsible for causing both the behavioral deficits and altered biophysical properties reported 
here. The morphological differences observed by TEM in vitro of Aβ 1-42 and Aβ 25-35 may explain 
the differences in their effects on the biophysical properties of key neurons of the learning and memory 
network, providing alternative pathways to the behavioral deficits observed. It appears that the larger 
crystalline structures formed by Aβ 25-35 lead to the reversal of learning-induced membrane depo-
larization, which is sufficient for the memory deficits observed. In contrast, the Aβ 1-42 peptide forms 
oligomeric species that lead to memory loss via alternative mechanisms, likely synaptic in nature. While 
the health of the CGC was confirmed in our electrophysiological studies based on recording from the 
cell body, future investigations will need to address the health of the synapses, which have been shown 
to be targets for Aβ and the first parts of neurons to become dysfunctional3,9,12.
The proposed circuit level actions of Aβ 25-35 and Aβ 1-42 in classically conditioned animals are 
summarized in Fig. 8. After classical conditioning and in the absence of elevated Aβ levels, the depolar-
ized CGC gates in the CS-mediated activation of the feeding response, while the US-mediated activation 
of the same circuit is mediated by a parallel pathway not affected by classical conditioning (Fig. 8a). Aβ 
25-35, but not Aβ 1-42, targets the CGC and reverses its depolarized state (Fig. 8b), resulting in the loss 
of the feeding response to the CS. Although Aβ 1-42 also causes the loss of the conditioned response, it 
is not doing so by affecting the CGC soma. However, based on the detailed information we have about 
the feeding circuit and the findings from the present study, we can formulate some hypotheses about its 
cellular targets. It is unlikely to target the soma of a so far unidentified neuron that plays a key role in 
long-term memory similar to the CGC, as previous work has shown that the learning-induced depolar-
ization of the CGC is sufficient for LTM21,22. Also, because the feeding Central Pattern Generator (CPG) 
itself remains functional, as demonstrated by the ability of the Aβ treated animals to respond to the 
unconditioned food stimulus (Supplementary Fig. 2a), Aβ 1-42 must be targeting a component of the 
CS to CPG pathway. It is unlikely to hyperpolarize the soma of the Cerebral Buccal Interneuron (CBI) 
type cells as previous experiments have shown that this leads to changes in the fictive feeding motor 
pattern29 that also would be manifested at the behavioral level. As the CBIs have a powerful modulatory 
control over the feeding CPG during sucrose-induced fictive feeding in semi-intact preparations29 it is 
also unlikely that the CBI to CPG synapses are affected by Aβ 1-42 as again, this would be manifested at 
the level of unconditioned feeding behavior. The most likely scenario is that Aβ 1-42 is targeting the CGC 
to CS sensory neuron and/or CS sensory neuron to CBI synapses (Fig. 8b) as this would only impair the 
animals’ response to the CS but not to the US. We cannot rule out either that it targets the CS sensory 
neuron to CGC input, which would reduce the CS induced weak increase in CGC spike frequency which 
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operates in conjunction with the somal depolarization to activate the CS sensory neuron to CBI synap-
tic input23. There are numerous examples of Aβ 1-42 interfering with synaptic mechanisms mediating 
aspects of learning and memory in other systems2 so it is plausible that it acts in a similar manner in the 
Lymnaea brain. It is also possible that Aβ 25-35 has an effect on the same synapses as Aβ 1-42, however, 
based on the current and previous studies21,22, its effect on the CGC soma alone would be sufficient to 
lead to behavioral memory impairment. The Aβ induced memory impairment seems to be dependent 
upon the animals having been trained, since treatment prior to training caused neither memory defi-
cits nor Aβ 25-35 induced changes in membrane properties. Further work will need to be undertaken 
to establish the molecular mechanisms underlying the selective effect of Aβ on cellular and molecular 
pathways of established memory.
Methods
Experimental animals. Pond snails, Lymnaea stagnalis, were bred at the University of Sussex and 
maintained in large holding tanks containing 18-22°C copper-free water, at a 12:12 hour light-dark cycle. 
The animals were fed Tetra-Phyll (TETRA Werke) twice a week and lettuce three times a week.
Preparation and systemic application of Aβ peptides. Aβ 1-42 was prepared in normal saline 
solution17 for maximally soluble oligomeric morphology, as previously described30. Briefly, 0.2 mg Aβ 
1-42 (rPeptide) was solubilized in 200 μ L HFIP (Sigma-Aldrich) to disaggregate the peptide. The solution 
Figure 8. The proposed cellular and circuit mechanisms of Aβ-induced loss of memory retention in 
Lymnaea. (a) Twenty-four hours after training, the membrane potential of the CGC soma and proximal 
axonal segments are persistently depolarized (indicated by green outlines) allowing the gating in of CS-
evoked sensory input to the CBI cells (Cerebral Buccal Interneurons). The CBIs in turn activate interneurons 
of the feeding central pattern generator (CPG) to generate the rhythmic motor pattern underlying the 
conditioned feeding response to the CS. Unconditioned food stimuli (such as sucrose) activate feeding via 
a parallel pathway not affected by classical conditioning. MNs, motoneurons of the feeding system. (b) 
Treatment with Aβ 25-35 and Aβ 1-42 at 24 hours after training both lead to memory loss 24 hours later 
(no feeding response to CS). Aβ 25-35, but not Aβ 1-42, targets the CGC soma and resets its membrane 
potential to the untrained level resulting in the removal of downstream effects of the depolarized soma 
membrane, which prevents the conditioned feeding response to be activated by the CS. Aβ 1-42 does not 
affect the CGC soma and may exert its memory impairing effect by affecting the SN to CGC, CGC to SN 
and/or SN to CBI synapses (areas in blue circles), which also may be affected by Aβ 25-35 in addition to its 
primary effect on somal membrane potential. Neither peptide affects the US pathway, the CBIs, the feeding 
CPG, or motoneurons and the synapses connecting these components of the feeding network and therefore 
the animals remain capable of responding to unconditioned food stimuli.
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was then vortexed on high for one minute and sonicated in a 50/60 Hz bath sonicator for one minute. 
The HFIP was then dried completely using a low stream of nitrogen gas for five to ten minutes. To ensure 
complete removal of HFIP, the sample was placed in a dessicator for 30 minutes. Once completely dried, 
200 μ L dry DMSO (Sigma-Aldrich) was added to the Aβ 1-42, vortexed for one minute, and sonicated 
for one minute. The Aβ 1-42 was then added to a prepared Zeba buffer-exchange column with 40 μ L 
normal saline solution as a stacking buffer and centrifuged for 30 minutes at 16k RPM. Using a molar 
absorption coefficient of 1490 M−1 cm−1, protein concentration was assessed by measuring at 280 nm 
using a NanoDrop spectrophotometer. The peptide was then diluted using normal saline to a final con-
centration of 1 μ M.
To prepare Aβ 25-35 for systemic injection, 0.25 mg Aβ Fragment 25-35 (Sigma- Aldrich) was mixed 
with 1.25 mL copper-free water and left to incubate for two hours to allow the peptide to solubilize and 
assemble. After two hours, the sample was diluted with normal saline solution to a final concentration of 
1 μ M or 0.1 mM. The peptides were administered to the animals directly after preparation. Using a 1 mL 
syringe with 30 gauge precision glide needles (Becton Dickinson), 100 μ L of the Aβ 25-35 or Aβ 1-42 
peptide solution was injected into the hemolymph (~1 mL in volume) of each snail. The estimated final 
concentration in the animal was 0.1 μ M for Aβ 1-42 and 0.1 μ M or 10 μ M for Aβ 25-35. As there is no 
blood-brain barrier in Lymnaea17, the injected peptides have direct access to the animal’s central nervous 
system. For vehicle-injected control animals, 100 μ L of normal saline was injected.
Preparation and imaging of Alexa Fluor 488 tagged Aβ 1-42. The protocol for preparation was 
fully described previously30. Briefly, an Alexa Fluor 488 Protein Labeling Kit (Invitrogen) was used to 
label the freshly solubilized Aβ 1-42 (described above), following the manufacturer’s instructions. Aβ 
1-42 was prepared as normal up to the DMSO stage, where kit components were added to the vial and 
allowed to incubate for 15 minutes at 21 °C. Tagged-peptide was then run on a 2 mL Zeba buffer-exchange 
spin column with 40 μ L normal saline solution as a stacking buffer and centrifuged for 30 minutes at 16k 
RPM, to remove any free tag from the solution. Protein concentration was measured as described for Aβ 
1-42 preparation with the addition of a measurement at 495 nm and 0.11 correction factor to account 
for the added Alexa Fluor 488 tag, and degree of labeling was then assessed using the molar extinction 
coefficient of the Alexa Fluor 488 of 71,000 M−1 cm−1. Protein labeling was low, 0.042 moles dye per 
moles protein, likely due to the low concentration of peptide (less than 2 mg/mL) used, as suggested by 
the manufacturer. Tagged-Aβ 1-42 was diluted to 1 μ M in normal saline solution.
For wholemount fluorescent imaging of Alexa Fluor 488 tagged Aβ 1-42, snail brains were dissected 
and the desheathed brains were immediately placed on glass slides with coverslips and imaged using 
an Olympus BX61WI with a 10 × 1.0 NA dipping objective and excitation and emission filters 470/22. 
Images were taken using an EMCCD camera (Andor iXon), processed using μ Manager software31, and 
binned at 1 × 1.
For TEM, buccal and cerebral ganglia were dissected and prepared for immunogold labeling using 
a previously described protocol involving minimal, cold fixation and embedding in Unicryl resin30,32. 
Briefly, thin (100 nm) sections were labeled with 1 μ g/mL rabbit antibody specific for Alexa Fluor 488 
(Molecular Probes). They were then labeled with a goat anti-rabbit 10 nm gold-conjugated secondary 
antibody (BBI Solutions OEM Ltd., Cardiff, UK) and stained with 2% aqueous uranyl acetate. The labeled 
thin sections were examined in a Hitachi 7100 TEM at 100 kV and digital images acquired with an axially 
mounted (2K x 2K pixel) Gatan Ultrascan 1000 CCD camera (Gatan UK, Oxford, UK).
Formic acid extracted hemolymph preparation. After 24 hours in vivo incubation of either Aβ 
1-42 or Aβ 25-35, a 1 mL syringe with 30 gauge precision glide needles (Becton Dickinson) was used 
to extract roughly 1 mL of hemolymph from each snail. Each sample was submitted to formic acid 
extraction, a method of removing soluble Aβ from tissue samples33. 1 mL of pooled hemolymph sample 
was mixed with 1 mL 0.4% diethylamine/100 mM NaCl. 400 μ L was then centrifuged at 14K RPM for 
1 hour at 4 °C. The supernatant was removed and 200 μ L 1 M Tris Base pH 7.4 was added to the pellet. 
400 μ L cold formic acid was then added. The sample was sonicated for 20 seconds and then 400 μ L was 
centrifuged at 14K RPM for 1 hour at 4 °C. 210 μ L of the supernatant was diluted into 4 mL Formic Acid 
Neutralization Buffer (1 M Tris Base, 0.5 M Na2HPO4) and 2 mL of this mixture was centrifuged at 14K 
RPM for 1 hour at 4 °C. The supernatant was then neutralized with 1/10 volume 1 M Tris Base (pH 6.8). 
The samples were stored at − 80 °C until used for imaging.
TEM negative stain. Formic acid extracted hemolymph samples were prepared for TEM nega-
tive stain to quantify soluble, oligomeric Aβ within the animals’ body fluids. 4 μ L of each sample were 
pipetted on to Formvar/carbon coated 400-mesh copper grids (Agar Scientific, Essex, UK) for 1 minute. 
Excess liquid was removed with Whatman paper. Grids were washed with 4 μ L of Milli-Q water and 
blotted, followed by 4 μ L of filtered 2% (w/v) uranyl acetate for 1 minute and blotted again. Grids were 
allowed to air dry before being examined in a Hitachi 7100 TEM at 100 kV and digital images acquired 
with an axially mounted (2K x 2K pixel) Gatan Ultrascan 1000 CCD camera (Gatan UK, Oxford, UK). 
After initial imaging, the samples were immunogold labeled (as previously described) to determine oli-
gomeric structure. A 1 μ g/mL mouse Nu1 primary antibody (Klein laboratory)16 and a goat anti-mouse 
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10 nm gold-conjugated secondary antibody (BBI Solutions OEM Ltd., Cardiff, UK) were used and grids 
were imaged as stated previously.
Negative staining of Aβ 1-42 and Aβ 25-35 was used to determine peptide morphology. Aliquots of 
94 μ M Aβ 25-35 and 100 μ M Aβ 1-42 were allowed to incubate in normal saline solution for 0, 3, or 
24 hours. Samples were prepared and images acquired as stated above.
Single-trial food-reward classical (CS + US) conditioning. Using well-established methods21, 
four- to six-month-old snails were removed from their home tanks and starved in new tanks for two 
days at the same temperature and light dark cycle as the home tanks. After the starvation period, the 
animals underwent single-trial food-reward classical conditioning in which the CS (amyl acetate: 0.004% 
final concentration) and the US (sucrose: 0.6% final concentration) were paired. Initially, each individual 
snail was left to acclimatize in a 14 cm diameter Petri dish with 90 mL of 18-22°C copper-free water for 
ten minutes. After the acclimatization period, 5 mL of amyl acetate was added to the dish and after thirty 
seconds, 5 mL of sucrose was added. The snails were then left in their Petri dishes for two minutes, and 
then removed to their starvation tanks. Both the vehicle-injected and Aβ -injected groups were trained. 
The naïve groups were not trained, but underwent the same starvation/feeding schedule and handling.
Forty-eight hours after training, all animals were tested for LTM with the CS. Each individual snail 
was left to acclimatize in a 14 cm-diameter Petri dish with 90 mL of 18-22°C copper-free water for ten 
minutes. After the acclimatization period, 5 mL of 18-22°C copper-free water was added to the dish. 
Rasps, the animals’ feeding movements, were manually counted for two minutes to determine a base-
line rasping rate (number of rasps per two minutes) for each individual. After two minutes, 5 mL amyl 
acetate was added to the dish. Rasping was tracked for two minutes. Rasping rates were determined by 
subtracting the individual animal’s baseline rasp from the amyl acetate induced rasp. A separate group 
of Aβ-treated naïve animals were tested for their ability to produce the unconditioned feeding motor 
response to the US 24 hours post injection. Snails from the same home tanks as those used in the classical 
conditioning paradigm were submitted to the same starvation and acclimatization procedures. However, 
these animals did not undergo training, only Aβ or vehicle injection and testing. After the acclimati-
zation period, 5 mL of 18-22 °C copper-free water was added to the dish. Rasping was tracked for two 
minutes to determine a baseline rasping rate for each individual then 5 mL sucrose was added to the dish 
and rasping was tracked for another two minutes.
Cell death and apoptosis measurements. For the cell morphology analysis, TEM was used to 
examine buccal and cerebral ganglia as detailed above. Images were then qualitatively scored for the 
health of the nucleolus, nuclear envelope, cellular membrane, and chromatin on a scale of 0 to 2, with 
0 = unhealthy 1 = uncertain 2 = healthy.
For the Annexin V-Alexa Fluor 488 analysis, buccal and cerebral ganglia were dissected and pinned 
on to a sylgard square. Samples were immediately placed in 4% paraformaldehyde (in 0.2 M phosphate 
buffer, pH 7.2) for 1 hour and then transferred to a 30% sucrose in phosphate buffered saline (PBS) 
solution overnight at 4 °C. Samples were removed from the sylgard square, coated in OCT embedding 
medium (VWR), and frozen in liquid nitrogen. Samples were sliced to 14 μ m thickness using a Cryostat 
and placed on to SuperFrost Plus slides (VWR). Slides were then allowed to dry for at least 30 minutes 
before being washed three times for two minutes each in PBS. 500 μ L of 4% normal goat serum in PBS 
was then added to each slide for 1 hour. Slides were again washed three times for two minutes in PBS 
and then labeled with 100 μ L Annexin V- Alexa Fluor 488 (1/500 dilution in PBS) (Invitrogen) per slide, 
coverslipped, and allowed to incubate in the dark at 4 °C. Slides received three final washes in PBS for 
two minutes each before 6 drops of Fluoroshield (Sigma Aldrich) was added to each slide, along with 
a coverslip. Slides were allowed to dry and samples were imaged using an Olympus BX61WI with a 
10 × 1.0 NA dipping objective and excitation and emission filters 470/22. Images were taken using an 
EMCCD camera (Andor iXon), processed using μ Manager software30, and binned at 2 × 2. Images were 
analyzed using ImageJ software and measured for area, mean, integrated density, and background signal 
mean all on the same ImageJ default setting for threshold. Final signal intensity was calculated using the 
Corrected Total Ganglia Fluorescence (CTGF) formula: CTGF = Integrated Density – (Area of selected 
ganglia X Mean fluorescence of background reading).
The TUNEL assay (Roche) analysis was performed using the same method as the Annexin V-Alexa 
Fluor 488 analysis. Samples were prepared, sectioned, and added to slides as previously mentioned. 
Sections were permeabilized in 0.1% Triton-X in PBS for 2 minutes on ice. Sections on the positive con-
trol slides were then treated with DNase I in Tris-HCl for 10 minutes, and all slides were labeled with 
TUNEL reaction mixture for 60 minutes at 37 °C except for the negative control, which were only labeled 
with the Label Solution. Slides received two final washes in PBS for two minutes each before 6 drops 
of Fluoroshield (Sigma Aldrich) was added to each slide, along with a coverslip. Slides were then dried, 
imaged, and analyzed as previously mentioned.
Electrophysiology. The two electrode current-clamp-based electrophysiological methods used in 
this study on the CGC have been described elsewhere21. Briefly, the CNS was dissected and pinned 
in a sylgard-coated dish containing Lymnaea physiological saline. The cerebral ganglia (location of the 
CGCs) were desheathed using fine forceps and treated with a solid protease (Sigma, XIV) for 1 min to 
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soften the inner-sheath. Intracellular recordings were made using sharp electrodes (5-20 MΩ ) filled with 
4 M potassium acetate. Axoclamp 2A (Axon Instrument, Molecular Device) and NL 102 (Digitimer Ltd) 
amplifiers were used and data acquired using a micro 1401 Mk II interface and analyzed using Spike 2 
software (Cambridge Electronic Design). Two-electrode current clamp techniques were used to measure 
the membrane properties of the CGC. The CGC membrane potential and action potential characteristics 
(action potential amplitude, half-width, and after-hyperpolarization amplitude) were determined over a 
100 s period recorded 120 s after electrode impalement. To test CGC membrane resistance, the cell was 
held at − 70 mV and injected with five − 2 nA 2 s duration current pulses.
Statistical analysis. Data that passed the D’Agostino and Pearson omnibus normality test were sub-
jected to parametric tests (one-way ANOVA with Tukey’s multiple comparison, or t-tests) to establish 
significance (criterion, p < 0.05). GraphPad Prism software was used for all analyses.
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